One of the primary challenges faced in drug R&D is the failure of many clinical trials due to inadequate patient selection or the lack of reliable biomarkers or indicators for therapeutic benefits. This lecture will address these challenges and improve the success rate of drug development.
|Date:||02 June 2023 (Friday)|
|Time:||3:00 – 5:00 p.m.|
|Title:||Key Considerations in Early Druggability Evaluation of Chemical Drugs|
|Speaker:||Dr. Ming Li, CEO of ZSHK Laboratories Limited|
|Audience:||All staff and students are welcome|